News

Zydus Lifesciences gets USFDA nod for its painkiller Celecoxib capsules
The company said that the medicine is used to treat pain or inflammation caused by many conditions such as arthritis, ...
InvestorsHub on MSN34m
ProKidney Shares Dip Following FDA Agreement on Rilparencel Approval Strategy
ProKidney Corp. (NASDAQ:PROK) saw its stock drop 11% in early trading before recovering somewhat to close down 3%, after ...
US ice cream makers say they’ll stop using artificial dyes by 2028
Ice cream makers representing about 90% of the U.S. supply of the frozen treat have pledged to remove artificial dyes from ...
The Manila Times58m
ZEVASKYN™ Gene Therapy Now Available at New Qualified Treatment Center in San Francisco Bay Area
- ZEVASKYN is the only FDA-approved therapy to treat RDEB wounds with a single application - ...
The Manila Times58m
ProKidney Announces Alignment with the FDA on the Accelerated Approval Pathway for Rilparencel
FDA confirmed that eGFR slope is an acceptable surrogate endpoint for accelerated approval of rilparencel in patients with CKD and type 2 diabetesFDA also confirmed that the ongoing Phase 3 PROACT 1 ...